Literature DB >> 1498329

Monoclonal antibody-based therapies of leukemia and lymphoma.

M L Grossbard1, O W Press, F R Appelbaum, I D Bernstein, L M Nadler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1498329

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

Review 1.  Radioimmunotherapy in mantle cell lymphoma.

Authors:  Alan P Skarbnik; Mitchell R Smith
Journal:  Best Pract Res Clin Haematol       Date:  2012-05-09       Impact factor: 3.020

Review 2.  Monoclonal antibodies in cancer therapy.

Authors:  R Gruber; E Holz; G Riethmüller
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Radioimmunotherapy: no news from the newcomer.

Authors:  A M Mello; E K Pauwels; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 4.  Monoclonal antibody therapy in Langerhans cell histiocytosis--feasible and reasonable?

Authors:  K M Kelly; J Pritchard
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 5.  An Update on the Clinical Evaluation of Antibody-Based Therapeutics in Acute Myeloid Leukemia.

Authors:  Sangeetha Venugopal; Naval Daver; Farhad Ravandi
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

Review 6.  Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.

Authors:  G Fleckenstein; R Osmers; J Puchta
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

7.  Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Authors:  K Chang; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Mechanisms in removal of tumor by antibody.

Authors:  G T Stevenson; A J Bell; T R Evans; R R French; M J Glennie; T J Hamblin; K S Kan; G M Mead
Journal:  Cell Biophys       Date:  1994

9.  Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19.

Authors:  L T Vlasveld; A Hekman; F A Vyth-Dreese; C J Melief; J J Sein; A C Voordouw; T A Dellemijn; E M Rankin
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

10.  Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.

Authors:  E Legouffe; J Liautard; J P Gaillard; J F Rossi; J Wijdenes; R Bataille; B Klein; J Brochier
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.